The role of TNF-α during Wallerian degeneration

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 147-152

  Liefner, M ^a   Siebert, H ^a,b   Sachse, T ^a   Michel, U ^a   Kollias, G ^c   Bruck W ^a,b,d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemotaxis; Macrophages; TNF ; Wallerian degeneration

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CHEMOTAXIS; CONTROLLED STUDY; MACROPHAGE; MOUSE; MYELIN SHEATH; NERVE DEGENERATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SCIATIC NERVE;

ANIMALS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MYELIN SHEATH; PHAGOCYTOSIS; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA; WALLERIAN DEGENERATION;

EID: 0034255882     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00262-9     Document Type: Article

References (54)

1. Aggarwal, B.B., Kohr, W.J., Hass, P.E., Moffat, B., Spencer, S.A., Henzel, W.J., Bringman, T.S., Nedwin, G.E., Goeddel, D.V., Harkins, R.N., 1985. Human tumor necrosis factor. J. Biol. Chem. 260, 2345-2354.
2. Baggiolini, M., Dewald, B., Moser, B., 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55, 97-179.
3. Barbara, J.A.J., van Ostade, X., Lopez, A.F., 1996. Tumor necrosis factor-α (TNF-α): The good, the bad and potentially very effective. Immunol. Cell Biol. 74, 434-443.
4. Barton, D.M., Ruddle, N.H., 1994. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51, 123-133.
5. Bernard, C., Barnier, P., Merval, R., Esposito, B., Tedgui, A., 1995. Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall. J. Cardiovasc. Pharmacol. 25 (Suppl. 2), S30-S33.
6. Beuche, W., Friede, R.L., 1984. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13, 767-796.
7. Bisby, M.A., Chen, S., 1990. Delayed Wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res. 530, 117-120.
8. Brück, W, 1997. The role of macrophages in Wallerian degeneration. Brain Pathol. 7, 741-752.
9. Brück, W, Brück, Y., Friede, R.L., 1992. TNF-α suppresses CR3-mediated myelin removal by macrophages. J. Neuroimmunol. 38, 9-18.
10. Brück, W., Friede, R.L., 1990a. Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 80, 415-418.
11. Brück, W., Friede, R.L., 1990b. L-Fucosidase treatment blocks myelin phagocytosis by macrophages in vitro. J. Neuroimmunol. 27, 217-227.
12. Brück, W., Friede, R.L., 1991. The role of complement in myelin phagocytosis during PNS Wallerian degeneration. J. Neurol. Sci. 103, 182-187.
13. Brück, W., Huitinga, I., Dijkstra, C.D., 1996. Liposome-mediated monocyte depletion during Wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J. Neurosci. Res. 46, 477-484.
14. Carroll, S.L., Frohnert, P.W., 1998. Expression of JE (monocyte chemoattractant protein-1) is induced by sciatic axotomy in wild type rodents but not in C57BL/Wld mice. J. Neuropathol. Exp. Neurol. 57, 915-930.
15. Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., Williamson, B., 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
16. Cavaillon, J.M., 1994. Cytokines and macrophages. Biomed. Pharmacother. 48, 445-453.
17. Créange, A., Barlovatz-Meimon, G., Gherardi, R.K., 1997. Cytokines and peripheral nerve disorders. Eur. Cytokine Netw. 8, 145-151.
18. da Costa, C., van der Laan, L.J.W., Dijkstra, C.D., Brück, W, 1997. The role of the mouse macrophage scavenger receptor in myelin phagocytosis. Eur. J. Neurosci. 9, 2650-2657.
19. DeForge, L.E., Remick, D.G., 1991. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem. Biophys. Res. Commun. 174, 18-24.
20. DeLeo, J.A., Colburn, R.W., Rickman, A.J., 1997. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759, 50-57.
21. Fernandez-Valle, C., Bunge, R.P., Bunge, B.M., 1995. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J. Neurocytol. 24, 667-679.
22. Fujioka, T., Kolson, D.L., Rostami, A.M., 1999. Chemokines and peripheral nerve demyelination. J. Neurovirol. 5, 27-31.
23. Hurwitz, A.A., Lyman, W.D., Berman, J.W., 1995. Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1. J. Neuroimmunol. 57, 193-198.
24. Jue, D.-M., Sherry, B., Luedke, C., Manogue, K.R., Cerami, A., 1990. Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29, 8371-8377.
25. Kriegler, M., Perez, C., DeFay, K., Albert, I., Lu, S.D., 1988. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53, 45-53.
26. Law, S.K.A., 1988. C3 receptors on macrophages. J. Cell Sci. Suppl. 9, 67-97.
27. Malek, N.P., Pluempe, J., Kubicka, S., Manns, M.P., Trautwein, C., 1998. Molecular mechanisms of TNF receptor-mediated signaling. Rec. Res. Cancer Res. 147, 97-106.
28. Mandell, G.L., 1995. Cytokines, phagocytes, and pentoxifylline. J. Cardiovasc. Pharmacol. 25 (Suppl. 2), S20-S22.
29. Neuner, P., Klosner, G., Pourmojib, M., Knobler, R., Schwarz, T., 1997. Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology 90, 435-439.
30. Oka, N., Akiguchi, I., Kawasaki, T., Mizutani, K., Satoi, H., Kimura, J., 1998. Tumor necrosis factor-α in peripheral nerve lesions. Acta Neuropathol. 95, 57-62.
31. Pasparakis, M., Alexopoulou, L., Episkopou, V., Kollias, G., 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411.
32. Pfizenmaier, K., Wajant, H., Grell, M., 1996. Tumor necrosis factors in 1996. Cytokine Growth Factor Rev. 7, 271-277.
33. Redford, E.J., Hall, S.M., Smith, K.J., 1995. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 118, 869-878.
34. Renno, T., Krakowski, M., Piccirillo, C., Lin, J., Owens, T., 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154, 944-953.
35. Rieckmann, P., Weber, F., Günther, A., Martin, S., Bitsch, A., Broocks, A., Kitze, B., Weber, T., Börner, T., Poser, S., 1996. Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J. Neuroimmunol. 64, 193-200.
36. Rollins, S.A., Sims, P.J., 1990. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 144, 3478-3483.
37. Selmaj, K., Raine, C.S., Cannella, B., Brosnan, C.F., 1991b. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
38. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T., Brosnan, C.F., 1991a. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
39. Sommer, C., Schäfers, M., 1999. Painful mononeuropathy in C57BL/ WLD mice with delayed Wallerian degeneration: different effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784, 154-162.
40. Stoll, G., Griffin, J.W., Li, C.Y., Trapp, B.D., 1989. Wallenan degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18, 671-683.
41. Stoll, G., Hartung, H.-P., 1992. The role of macrophages in degeneration and immune-mediated demyelination of the peripheral nervous system. Adv. Neuroimmunol. 2, 163-179.
42. Stoll, G., Jander, S., Jung, S., Archelos, J., Tamatani, T., Miyasaka, M., Toyka, K.V., Hartung, H.-P., 1993b. Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system. Lab. Invest. 68, 637-644.
43. Stoll, G., Jung, S., Jander, S., van der Meide, P., Hartung, H.-P., 1993a. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45, 175-182.
44. Tanaka, K., Zhang, Q.-L., Webster, H.d., 1992. Myelinated fiber regeneration after sciatic nerve crush: morphometric observations in young adult and aging mice and the effects of macrophage suppression and conditioning lesions. Exp. Neurol. 118, 53-61.
45. Tchelingerian, J.-L., Monge, M., Le Saux, F., Zalc, B., Jacque, C., 1995. Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J. Neurochem. 65, 2377-2380.
46. Toews, A.D., Barrett, C., Morell, P, 1998. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J. Neurosci. Res. 53, 260-267.
47. Uguccioni, M., D'Apuzzo, M., Loetscher, M., Dewald, B., Baggiolini, M., 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, Rantes, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25, 64-68.
48. Uncini, A., di Muzio, A., di Guglielmo, G., de Angelis, M.V., de Luca, G., Lugaresi, A., Gambi, D., 1999. Effect of rhTNF-α injection into rat sciatic nerve. J. Neuroimmunol. 94, 88-94.
49. van der Laan, L.J.W., Ruuls, S.R., Weber, K.S., Lodder, I.J., Döpp, E.A., Dijkstra, C.D., 1996. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-a and nitric oxide. J. Neuroimmunol. 70, 145-152.
50. van Oosten, B.W., Rep, M.H.G., van Lier, R.A.W., Scholten, P.E.T., von Blomberg, B.M.E., Pflughaupt, K.W., Hartung, H.-P, Ader, H.J., Polman, C.H., 1996. A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis. J. Neuroimmunol. 66, 49-55.
51. Vougioukas, V.I., Roeske, S., Michel, U., Brück, W., 1998. Wallerian degeneration in ICAM-1-deficient mice. Am. J. Pathol. 152, 241-249.
52. Wagner, R., Myers, R.R., 1996. Schwann cells produce tumor necrosis factor α: expression in injured and non-injured nerves. Neuroscience 73, 625-629.
53. Wang, J.M., Walter, S., Mantovani, A., 1990. Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. Immunology 71, 364-367.
54. Weber, K.S., Klickstein, L.B., Weber, C., 1999. Specific activation of leukocyte β2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the α subunit cytoplasmic domains. Mol. Biol. Cell 10, 861-873.